Correction: Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: A Danish Nationwide Cohort Study (JAMA Internal Medicine (2014) 174, 3 (336-344) DOI: 10.1001/jamainternmed.2013.11349);Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: A Danish nationwide cohort study

JAMA Internal Medicine

Volumn 174, Issue 3, 2014, Pages 336-344

  Andersson, Charlotte ^a,b,f   Mérie, Charlotte ^b   Jørgensen, Mads ^b   Gislason, Gunnar H ^b,c   Torp Pedersen, Christian ^d   Overgaard, Charlotte ^d   Køber, Lars ^e   Jensen, Per Føge ^a,e   Hlatky, Mark A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d AALBORG UNIVERSITY   (Denmark)

^e University of Copenhagen   (Denmark)

^f NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LOOP DIURETIC AGENT;

AGED; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; COHORT ANALYSIS; CORONARY ARTERY BYPASS SURGERY; DISEASE ASSOCIATION; FEMALE; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREOPERATIVE CARE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COHORT STUDIES; DENMARK; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; POSTOPERATIVE COMPLICATIONS; PROPENSITY SCORE; REGISTRIES; RISK FACTORS; STROKE;

EID: 84895742704     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.11349     Document Type: Erratum

References (22)

1. Bangalore S,Wetterslev J, Pranesh S, Sawhney S, Gluud C, Messerli FH. Perioperative β blockers in patients having non-cardiac surgery: a meta-analysis. Lancet. 2008;372(9654):1962-1976.
2. Fleisher LA, Beckman JA, Brown KA, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery); American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Rhythm Society; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society for Vascular Surgery. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation. 2007;116(17):e418-e499.
3. Poldermans D, Bax JJ, Boersma E, et al; Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery; European Society of Cardiology (ESC). Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J. 2009;30(22):2769-2812.
4. Freemantle N, Cleland J, Young P, Mason J, Harrison J. β blockade aftermyocardial infarction: systematic review and meta regression analysis. BMJ. 1999;318(7200):1730-1737. (Pubitemid 29290470)
5. Packer M, Fowler MB, Roecker EB, et al Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study. Circulation. 2002;106(17):2194-2199. (Pubitemid 35222212)
6. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353(9146):9-13.
7. Bangalore S, Steg G, Deedwania P, et al; REACH Registry Investigators. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA. 2012;308(13):1340-1349.
8. Badner NH, Knill RL, Brown JE, Novick TV, Gelb AW.Myocardial infarction after noncardiac surgery. Anesthesiology. 1998;88(3):572-578. (Pubitemid 28120188)
9. Talati R, Reinhart KM, White CM, et al. Outcomes of perioperative β-blockade in patients undergoing noncardiac surgery: ameta-analysis. Ann Pharmacother. 2009;43(7):1181-1188.
10. Devereaux PJ, Yang H, Yusuf S, et al; POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371(9627):1839-1847.
11. Andersson C, Lyngbæk S, Nguyen CD, et al. Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes. JAMA. 2012;308(9):882-889.
12. Schramm TK, Gislason GH, Køber L, et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a priormyocardial infarction carry the same cardiovascular risk: a population study of 3.3million people. Circulation. 2008;117(15):1945-1954. (Pubitemid 351543470)
13. Andersson C, Norgaard ML, Hansen PR, et al. Heart failure severity, as determined by loop diuretic dosages, predicts the risk of developing diabetes after myocardial infarction: a nationwide cohort study. Eur J Heart Fail. 2010;12(12):1333-1338.
14. Kümler T, Gislason GH, Kirk V, et al. Accuracy of a heart failure diagnosis in administrative registers. Eur J Heart Fail. 2008;10(7):658-660.
15. Fleisher LA, Beckman JA, Brown KA, et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009;120(21):e169- e276.
16. Poldermans D, Boersma E, Bax JJ, et al; Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med. 1999;341(24):1789-1794.
17. Zaugg M, Tagliente T, Lucchinetti E, et al. Beneficial effects from β-adrenergic blockade in elderly patients undergoing noncardiac surgery. Anesthesiology. 1999;91(6):1674-1686.
18. Devereaux PJ, Beattie WS, Choi PT, et al. How strong is the evidence for the use of perioperative β blockers in non-cardiac surgery? systematic review and meta-analysis of randomised controlled trials. BMJ. 2005;331(7512):313-321.
19. Lindenauer PK, Pekow P,Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005;353(4):349-361. (Pubitemid 41132339)
20. Madsen M, Davidsen M, Rasmussen S, Abildstrom SZ, Osler M. The validity of the diagnosis of acutemyocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol. 2003;56(2):124-130. (Pubitemid 36315938)
21. Johnsen SP, Overvad K, Sørensen HT, Tjønneland A, Husted SE. Predictive value of stroke and transient ischemic attack discharge diagnoses in the Danish National Registry of Patients. J Clin Epidemiol. 2002;55(6):602-607. (Pubitemid 34621504)
22. Devereaux PJ, Xavier D, Pogue J, et al; POISE (PeriOperative ISchemic Evaluation) Investigators. Characteristics and short-term prognosis of perioperativemyocardial infarction in patients undergoing noncardiac surgery: a cohort study. Ann Intern Med. 2011;154(8):523-528.